Skip to main content


Opinion: Three lessons from COVID-19 on accelerating biopharma innovation

By Stat News  
   September 18, 2020

The health care research ecosystem has shifted into overdrive in response to Covid-19, sparking unprecedented speed and agility. The economic and public health burdens it has generated demand that we rethink our approach to developing new vaccines and therapies. Researchers are now examining what we can learn from these experiences and more broadly apply this innovation to research and development in the future.

Full story

Get the latest on healthcare leadership in your inbox.